Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A study of colorectal cancer in a referral center

ABSTRACT: Primary outcome(s): To evaluate the demography and clinical presentation CRC patientsTimepoint: 5 years follow up for survival Study Design: Other Method of generating randomization sequence:Coin toss, Lottery, toss of dice, shuffling cards etc Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Outcome Assessor Blinded

DISEASE(S): Colorectal Cancer (adenocarcinoma)

PROVIDER: 2580595 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Effect of a drug (Oral Ivabradine) on BP and Heart Rate during putting endotracheal tube with laryngoscopy.

Project description:Intervention1: Tablet Ivabradine: Oral Ivabradine 5mg was given one hour before surgery Control Intervention1: tablet multivitamin: oral multivitamin(one tablet) one hour before surgery Primary outcome(s): Haemodynamics changesTimepoint: up to 10 min after laryngoscopy and intubation Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant, Investigator and Outcome Assessor Blinded

| 2757961 | ecrin-mdr-crc

Does local application of nitrates, during insertion of staplers via anal canal for bowel anastomosis prevent injury to muscles of anal canal ?

Project description:Intervention1: 0.2% Glyceryl Trinitrate: 1mg 0.2% glyceryl trinitrate, which corresponds to 2cm on the standardized measuring scale Control Intervention1: Nil: Nil Primary outcome(s): To compare anal sphincter pressure between intervention and observation groupsTimepoint: 1-3 days preoperative and 14-30 days postoperative Study Design: Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Outcome Assessor Blinded

| 2579582 | ecrin-mdr-crc

Comparison of pain in patient under going major surgery under general anaesthesia vs general and Epidural anaesthesia

Project description:Intervention1: General anaesthesia and epidural anesthesia vs only general anaesthesia and periopertive analgesia: 0-3-6-12-24hr Dose of ropivacaine 0.3/cc @4ml/hr acc to pt profile dose will be increased Control Intervention1: General anaesthesia only and periopertive analgesia: 0-3-6-12-24hr Primary outcome(s): Vas score assessment and need for inhalation agent perioperative periodTimepoint: 0-3-6-12-24hr Study Design: Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Outcome Assessor Blinded

| 2715133 | ecrin-mdr-crc

Comparison of two drugs ( inj dexmedetomidine and inj clonidine) in terms of recovery from anaesthesia

Project description:Intervention1: Dexmedetomidine and Clonidine: Drugs to be given before the end of surgery as infusion over 10 minutes Control Intervention1: Injection Dexmedetomidine: Injection Dexmedetomidine 1 Microgram / Kg at the end of surgery as infusion over 10 minutes Control Intervention2: Injection Clonidine: Injection Clonidine 3 Microgram /Kg as infusion over 10 minutes at the end of surgery Primary outcome(s): Haemodynamic stabilityTimepoint: Intraoperatively (1- 3 hours) Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant, Investigator and Outcome Assessor Blinded

| 29486 | ecrin-mdr-crc

Comparison of intubation using instruments as Ambu Auragain,fastrach LMA and Blockbuster LMA.

Project description:Intervention1: Tracheal intubation with supraglottic Airway devices: Comparison of tracheal intubation with Ambu AuraGain,fastrach Laryngeal Mask and Blockbuster Laryngeal Mask Airway. Control Intervention1: Ambu AuraGain: Tracheal intubation with Ambu AuraGain Control Intervention2: Fastrach Laryngeal Mask Airway: Tracheal intubation with Fastrach Laryngeal Mask Airway. Control Intervention3: Blockbuster Laryngeal Mask Airway: Tracheal intubation with Blockbuster Laryngeal Mask Airway. Primary outcome(s): First Attempt success rate of tracheal intubation.Timepoint: During intubation Study Design: Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Outcome Assessor Blinded

| 2605805 | ecrin-mdr-crc

Effect of turmeric extract in patients with colon cancer

Project description:Intervention1: Tab. Curcuma longa 550 mg: Tab. Curcuma longa 550 mg, 3 times a day daily from the day of initiation of chemotherapy to 8 cycles along with the CAPOX regimen Control Intervention1: Tab. Placebo: Tab. Placebo, 3 times a day daily from the day of initiation of chemotherapy to 8 cycles along with the CAPOX regimen Primary outcome(s): objective response rate (ORR) at the end of 8 cycles of treatment in metastatic colorectal patientsTimepoint: 0 cycle, 8 cycles of chemotherapy Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Permuted block randomization, variable Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Investigator Blinded

| 2758009 | ecrin-mdr-crc

Effects of oral melatonin and gabapentin on tube placement in trachea for anaesthesia in patient posted for surgery

Project description:Intervention1: Oral study drugs 120 min before induction of anaesthesia: To study Haemodynamic responses to both drugs Control Intervention1: Tablet Gabapentin: Oral Gabapentin 800 mg in study group will be given 120 min before induction of anaesthesia in double blind manner. Placebo tablets 120 min before induction of anaesthesia in control group Control Intervention2: Tab Melatonin: Tab melatonin 6 mg orally 120 min before induction of anaesthesia Primary outcome(s): SBP,DBP,MAP,HRTimepoint: Just after intubation,1min,3min,5min,10min Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant, Investigator and Outcome Assessor Blinded

| 2589334 | ecrin-mdr-crc

Use of ultrasound to measure stomach volume in patients who take a carbohydrate drink versus fully fasted patients before surgery.

Project description:Intervention1: Maltdextrin drink (Carboload): The patients randomised in Group C will receive 800 ml Carboload feeding at around 10 PM the night before surgery and further 400 mL Carboload at around 6 AM on the morning of surgery. Control Intervention1: Fasting: The patients in Group F will be fasted overnight and allowed water till 6 hours before surgery. Primary outcome(s): The primary outcome to be measured in the study will be the RGV (in mL) measured with ultrasound.Timepoint: Just before induction of anaesthesia. Study Design: Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Outcome Assessor Blinded

| 76748 | ecrin-mdr-crc

Comparison of two regimens of total intravenous anaesthesia for time to recovery from anaesthesia.

Project description:Intervention1: ADBIULFAUIPQP: FNRREUIQFNQI;QEIO;EQGBGR Intervention2: propofol and dexmedetomidine: infusion dexmedetomidine @1mcg/kg over 10 min folowed by infusion dexmedetomidine 0.5mcg/kg/hr. infusion propofol 200mcg/kg/min to maintain a BIS of 40-50 Control Intervention1: EWFVUKFVUY: W2VFUYO Control Intervention2: Propofol and Ketamine: INFUSION KETAMINE @1MG/KG OVER 10 MINS FOLLOWED BY INFUSION KETAMINE 0.5MG/KG/HR INFUSION PROPOFOL 200MCG/KG/MIN TITRATED TO MAINTAIN A BIS OF 40-50 Primary outcome(s): Time taken to achieve Modified Aldrete Score of â?¥9 (MeanÂ±SD) using propofol with ketamine or dexmedetomidineTimepoint: postoperative every minute till Modified Adrette Score is more than or equal to 9 Study Design: Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded

| 2601412 | ecrin-mdr-crc

The Effect of Anaesthetic Drugs on Recovery in Patients Undergoing Cancer surgery

Project description:Intervention1: KETAMINE: Patients will be randomised to receive low dose ketamine infusions @ 0.1 mg/kg/hr + GA + Epidural; ketamine infusion will be started around the time of skin incision Intervention2: DEXMEDETOMIDINE: : Dexmedetomidine IV infusions @ 0.25 mcg/kg/hr + GA + Epidural; dexmedetomidine infusion will be started around the time of skin incision around the time of incision Control Intervention1: NORMAL SALINE: 0.9 % Saline IV infusions @ 5 ml/hr Primary outcome(s): 1.To assess the effect of infusion of a low dose of ketamine and dexmedetomidine infusions vs placebo on the time to passage of flatus in patients undergoing GI malignancy surgeries.Timepoint: Post - Operatively 24 hrs to 72 hrs Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant, Investigator and Outcome Assessor Blinded

| 2582579 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data